132 related articles for article (PubMed ID: 24804306)
1. Genotype-guided dosing of vitamin K antagonists.
Maitland-van der Zee AH; de Boer A; Manolopoulos VG;
N Engl J Med; 2014 May; 370(18):1765-6. PubMed ID: 24804306
[No Abstract] [Full Text] [Related]
2. Genotype-guided dosing of vitamin K antagonists.
Pirmohamed M; Wadelius M; Kamali F;
N Engl J Med; 2014 May; 370(18):1764-5. PubMed ID: 24804303
[No Abstract] [Full Text] [Related]
3. Genotype-guided dosing of vitamin K antagonists.
Cavallari LH; Kittles RA; Perera MA
N Engl J Med; 2014 May; 370(18):1763. PubMed ID: 24785218
[No Abstract] [Full Text] [Related]
4. Genotype-guided dosing of vitamin K antagonists.
Koller EA; Roche JC; Rollins JA
N Engl J Med; 2014 May; 370(18):1761. PubMed ID: 24785214
[No Abstract] [Full Text] [Related]
5. Genotype-guided dosing of vitamin K antagonists.
Kimmel SE; French B; Geller NL;
N Engl J Med; 2014 May; 370(18):1763-4. PubMed ID: 24785213
[No Abstract] [Full Text] [Related]
6. Do pharmacogenetics have a role in the dosing of vitamin K antagonists?
Furie B
N Engl J Med; 2013 Dec; 369(24):2345-6. PubMed ID: 24251364
[No Abstract] [Full Text] [Related]
7. Pharmacogenetics and coumarin dosing--recalibrating expectations.
Zineh I; Pacanowski M; Woodcock J
N Engl J Med; 2013 Dec; 369(24):2273-5. PubMed ID: 24328463
[No Abstract] [Full Text] [Related]
8. Anticoagulation therapy: genotype-guided anticoagulation therapy-the jury is still out.
Roberts A
Nat Rev Cardiol; 2014 Jan; 11(1):1. PubMed ID: 24302217
[No Abstract] [Full Text] [Related]
9. Patients benefit from genetics-guided coumarin anticoagulant therapy.
Maitland-van der Zee AH; Daly AK; Kamali F; Manolopoulous VG; Verhoef TI; Wadelius M; de Boer A; Pirmohamed M;
Clin Pharmacol Ther; 2014 Jul; 96(1):15-7. PubMed ID: 24942396
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.
Verhoef TI; Ragia G; de Boer A; Barallon R; Kolovou G; Kolovou V; Konstantinides S; Le Cessie S; Maltezos E; van der Meer FJ; Redekop WK; Remkes M; Rosendaal FR; van Schie RM; Tavridou A; Tziakas D; Wadelius M; Manolopoulos VG; Maitland-van der Zee AH;
N Engl J Med; 2013 Dec; 369(24):2304-12. PubMed ID: 24251360
[TBL] [Abstract][Full Text] [Related]
11. Warfarin, genes, and the (health care) environment.
Kazi DS; Hlatky MA
JAMA Intern Med; 2014 Aug; 174(8):1338-9. PubMed ID: 24934523
[No Abstract] [Full Text] [Related]
12. The value of pharmacogenetic testing.
Pocinki AG
JAMA Intern Med; 2015 Feb; 175(2):314. PubMed ID: 25642672
[No Abstract] [Full Text] [Related]
13. The value of pharmacogenetic testing—reply.
Kazi DS; Hlatky MA
JAMA Intern Med; 2015 Feb; 175(2):314-5. PubMed ID: 25642673
[No Abstract] [Full Text] [Related]
14. Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon.
Verhoef TI; Redekop WK; Daly AK; van Schie RM; de Boer A; Maitland-van der Zee AH
Br J Clin Pharmacol; 2014 Apr; 77(4):626-41. PubMed ID: 23919835
[TBL] [Abstract][Full Text] [Related]
15. Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
Stergiopoulos K; Brown DL
JAMA Intern Med; 2014 Aug; 174(8):1330-8. PubMed ID: 24935087
[TBL] [Abstract][Full Text] [Related]
16. Genotype-guided dosing of vitamin K antagonists.
Daneshjou R; Klein TE; Altman RB
N Engl J Med; 2014 May; 370(18):1762-3. PubMed ID: 24785217
[No Abstract] [Full Text] [Related]
17. Genotype-guided dosing of vitamin K antagonists.
Pereira NL; Rihal CS; Weinshilboum RM
N Engl J Med; 2014 May; 370(18):1762. PubMed ID: 24785216
[No Abstract] [Full Text] [Related]
18. Genotype-guided dosing of vitamin K antagonists.
Schwarz UI; Kim RB; Tirona RG
N Engl J Med; 2014 May; 370(18):1761-2. PubMed ID: 24785215
[No Abstract] [Full Text] [Related]
19. [Effect of the -1639G > A polymorphism of the VKORC1 gene on the dose of oral anticoagulants acenocoumarol, and warfarin in Chilean patients: alternative models of inheritance].
López-Hernández D
Rev Med Chil; 2016 Apr; 144(4):539-41. PubMed ID: 27401392
[No Abstract] [Full Text] [Related]
20. Warfarin dosing by genotype did not improve time in therapeutic range.
Dunn A
Ann Intern Med; 2014 Mar; 160(6):JC8. PubMed ID: 24638186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
